Lo et al (Clinical Cancer Research 7: 1856-9, Jul. 2001).* |
Anker et al., “Detection of Circulating Tumour DNA in the Blood (Plasma/Serum) of Cancer Patients,” Cancer Metastasis Rev. 18:65-73 (1999). |
Anker et al.,“K-ras Mutations are Found in DNA Extracted from the Plasma of Patients with Colorectal Cancer,” Gastroenterology. 112:1114-1120 (1997). |
Chen et al.,“Microsatellite Alterations in Plasma DNA of Small Cell Lung Cancer Patients,” Nature Medicine. 2:1033-1035 (1996). |
Wong et al., “Detection of Aberrant p16 Methylation in the Plasma and Serum of Liver Cancer Patients,” Cancer Res. 59:71-3 (1999). |
Mutirangura et al., “Epstein-Barr Viral DNA in Serum of Patients with Nasopharyngeal Carcinoma,” Clin Cancer Res. 4:665-9 (1998). |
Lei et al., “Quantitative Analysis of Circulating Cell-Free Epstein-Barr Virus (EBV) DNA Levels in Patients with EBV-Associated Lymphoid Malignancies,” Br J Haematol. 111:239-46 (2000). |
Nawroz et al., Microsatellite Alterations in Serum DNA of Head and Neck Cancer Patients, Nat. Med., 2:1035-1037 (1996). |
Lo et al., “Quantitative Analysis of Cell-free Epstein-Barr Virus DNA in Plasma of Patients with Nasopharyngeal Carcinoma,” Clin. Cancer Res., 59:1188-1191 (1999). |
Capone, “Detection and Quantitation of Human Papillomavirus (HPV) DNA in the Sera of Patients with HPV-Associated Head and Neck Squamous Cell Carcinoma,” Clin. Cancer Res., 6:4171-4175 (2000). |
Cohen, “Epstein-Barr Virus Infection,” N.Engl. J. Med., 343:481-492 (2000). |
Drout et al., “High Epstein-Barr Virus Serum Load and Elevated Titers of Anti-ZEBRA Antibodies in Patients with EBV-Harboring Tumor Cells of Hodgkin's Disease,” J. Med. Virol., 57:383-389 (1999). |
Shibata et al., “Rapid Communication,” Am. J. Pathol., 140:769-774 (1992). |
Yuen et al., “In Situ Detection of Epstein-Barr Virus in Gastric and Colorectal Adenocarcinomas,” Am. J. Surg. Pathol., 18:1158-1163 (1994). |
Lo et al., “Quantitative and Temporal Correlation between Circulation Cell-Free Epstein-Barr Virus DNA and Tumor Recurrence in Nasopharyngeal Carcinoma,” Cancer Res., 59:5452-5455 (1999). |
Gallagher et al., “Detection of Epstein-Barr Virus (EBV) Genomes in the Serum of Patients with EBV-Associated Hodgkin's Disease,” Int. J. Cancer, 84:442-448 (1999). |
Lo et al., “Molecular Prognostication of Nasopharyngeal Carcinoma by Quantitative Analysis of Circulating Epstein-Barr Virus DNA,” Cancer Res., (in press). |
Sugawara et al., “Detection of Epstein-Barr Virus (EBV) in Hepatocellular Carcinoma Tissue: A Novel EBV Latency Characterized by the Absence of EBV-Encoded Small RNA Expression,” Virology. 256:196-202 (1999). |
Yanai et al., “Epstein-Barr Virus-Associated Gastric Carcinoma and Atrophic Gastritis, ” J Clin Gastroenterol. 29:39-43 (1999). |
Yoshimura et al., Gastric Mucosal Inflammation and Epithelial Cell Turnover are Associated with Gastric Cancer in Patients with Helicobactr Pylori Infection, J Clin Pathol, 53:532-6 (2000). |
Hui et al., “Epstein-Barr Virus-Associated Gastric Lymphoma in Hong Kong Chinese,” Hum. Pathol., 25:947-952 (1994). |
Rogers et al., “Excretion of Deoxyribonucleic Acid by Lymphocytes Stimulated with Phytohemagglutinin or Antigen, ” Proc. Natl. Acad. Sci. USA., 69:1685-1689 (1972). |
Shotelersuk et al., “Epstein-Barr Virus DNA in Serum/Plasma as a tumor Marker for Nasopharyngeal Cancer,” Clin. Cancer Res., 6:1046-1051 (2000). |
Lo, Y. et al.,“Kinetics of Plasma Epstein-Barr Virus DNA During Radiation Therapy for Nasopharyngeal Carcinoma,” Cancer Res., 60:2351-2355 (2000). |
Lo, Y. et al., “Rapid Clearance of Fetal DNA from Maternal Plasma,” Am. J. Hum. Genet., 64;218-224 (1999). |
Bonnet et al., “Detection of Epstein-Barr Virus in Invasive Breast Cancers,” J. Natl. Cancer Inst., 91:1376-1381 (1999). |